Examples of using Second-line in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
metastatic transitional cell carcinoma of the urothelium as second-line therapy after failure of a prior platinum- containing regimen.
Combination therapy in second-line treatment of metastatic colorectal cancer Data from a multicentre, randomised, controlled phase III clinical study(NO16967) support the use of Xeloda in combination with oxaliplatin for the second-line treatment of metastastic colorectal cancer.
more severe cases may require more aggressive“second-line” medications,
conducted in mCRC patients: first-line(NO16966), second-line with no previous bevacizumab treatment(E3200), and second-line with previous bevacizumab treatment following disease progression in first-line ML18147.
joint destruction are minimized when the condition is treated earlier with second-line drugs(disease-modifying antirheumatic drugs), even within months of the diagnosis.
Sequential treatment consisted of first-line capecitabine(1250 mg/m2 twice daily for 14 days), second-line irinotecan(350 mg/m2 on day 1),
combined with irinotecan(250 mg/ m2 on day 1)(XELIRI) and second-line capecitabine(1000 mg/ m2 twice daily for 14 days)
combined with irinotecan(250 mg /m2 on day 1)(XELIRI) and second-line capecitabine(1000 mg/m2 twice daily for 14 days)
in patients with highly active disease in which we know that the weaker drugs only mean the loss of valuable time recommended the introduction of second-line therapies such as Gilenya(fingolimoda),
Fifty-nine percent received study medicinal product as second or greater than second-line therapy.
Patients were enrolled in the first-line(N=61) or second-line setting(N=68) i.e. after failure of 1 prior chemotherapy regimen.
with levetiracetam and valproate as second-line due to issues of cost
The following undesirable effects relate to 107 AIDS-KS patients treated with 100 mg/m2 Paxene administered as a 3 hour infusion as second-line chemotherapy in a clinical study, and were considered possibly
to 166 MBC and 120 MOC patients treated with 175 mg/m2 Paxene administered as a 3-hour infusion as second-line chemotherapy in two clinical studies
The following undesirable effects relate to 107 AIDS-KS patients treated with 100 mg/ m2 Paxene administered as a 3 hour infusion as second-line chemotherapy in a clinical study, and were considered possibly
system administration, second-line support, training,
thrombocytopenic purpura splenectomised patients who are refractory to other treatments, and that it may be considered as second-line treatment for adult non-splenectomised patients where surgery is contra-indicated.
Pyrazinamide is a second-line anti-tuberculosis drug,
The drug is prescribed for bacterial lesions(as a second-line medication), provoked by microorganisms that have sensitivity to it.
It is considered a second-line treatment of choice for neurogenic bladder,